Pecquet S, Ravoire S, Andremont A
Institut Gustave-Roussy, Villejuif, France.
J Antimicrob Chemother. 1990 Jul;26(1):125-9. doi: 10.1093/jac/26.1.125.
High concentrations of ciprofloxacin have been shown to persist in the faeces of volunteers for several days after a week of oral treatment with this drug, which was also found to have a prolonged effect on aerobic Gram-negative intestinal bacteria. To determine whether a shorter course of ciprofloxacin would have the same prolonged effect, we treated ten healthy adult volunteers with a single oral dose of 750 mg ciprofloxacin and found that this was not followed by any significant changes in the counts of anaerobes or streptococci, but that there was a mean decrease of 2.5 log10 cfu/ml in the counts of faecal Enterobacteriaceae, which lasted for a full week. We attributed this to the persistence of high faecal ciprofloxacin concentrations for several days in all the volunteers. We did not observe any significant increase in the MICs of ciprofloxacin for faecal Enterobacteriaceae, or any faecal overgrowth of staphylococci, fungi, Pseudomonas aeruginosa or Clostridium difficile.
在志愿者口服环丙沙星一周后,高浓度的环丙沙星已被证明会在其粪便中持续存在数天,同时还发现该药物对需氧革兰氏阴性肠道细菌有延长作用。为了确定较短疗程的环丙沙星是否会有同样的延长作用,我们对10名健康成年志愿者单次口服750毫克环丙沙星进行治疗,发现这之后厌氧菌或链球菌数量没有任何显著变化,但粪便肠杆菌科细菌数量平均下降了2.5 log10 cfu/ml,且持续了整整一周。我们将此归因于所有志愿者粪便中环丙沙星高浓度持续了数天。我们未观察到粪便肠杆菌科细菌对环丙沙星的最低抑菌浓度有任何显著增加,也未观察到葡萄球菌、真菌、铜绿假单胞菌或艰难梭菌在粪便中的过度生长。